The content is available as a PDF (142.2 KB).
letter . 2020 Sep 2:hcaa259. doi: 10.1093/qjmed/hcaa259
EOSINOPENIA: An early, effective, and relevant COVID-19 biomarker?
Elena Roca
h1,✉, Laura Ventura
h3, Costanza M Zattra
h1, Carlo Lombardi
h2
Elena Roca
h1COVID-19 Unit, Departmental Unit, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy
Find articles by Elena Roca
Laura Ventura
h3Department of Statistical Sciences, University of Padova, Padova, Italy
Find articles by Laura Ventura
Costanza M Zattra
h1COVID-19 Unit, Departmental Unit, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy
Find articles by Costanza M Zattra
Carlo Lombardi
h2COVID-19 Unit & Departmental Unit of Pneumology & Allergology, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy
Find articles by Carlo Lombardi
h1COVID-19 Unit, Departmental Unit, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy
h2COVID-19 Unit & Departmental Unit of Pneumology & Allergology, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy
h3Department of Statistical Sciences, University of Padova, Padova, Italy
✉
Corresponding Author: Elena Roca MD, Covid-19 Unit, Head and Neck Department, Poliambulanza Fundation Hospital, Via Leonida Bissolati, 57, 25124 Brescia, Brescia (Italy), Phone: +39 3393667949, e-mail: rocaelena@gmail.com
Received 2020 Aug 18; Accepted 2020 Aug 20.
Keywords: Eosinopenia, SARS-CoV2, COVID-19 disease
© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7499754 PMID: 32877511